NAVB insider filings

NAVIDEA BIOPHARMACEUTICALS, INC. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-12-05. Screen NAVB transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for NAVB between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — NAVIDEA BIOPHARMACEUTICALS, INC.

FiledFormInsiderReported transactionsSource
2023-12-054Scott John K Jr. — Director, 10% ownerOther (J): 2,270 · Other (J): 2,400 (derivative) @ $1,000 · Other (J): 64,289 (derivative) @ $100EDGAR
2023-11-204Moss Dana J — DirectorGrant/award (A): 200,000 @ $0 · Grant/award (A): 416,667 @ $0EDGAR
2023-11-204Stefanelli Jill — DirectorGrant/award (A): 275,000 @ $0 · Grant/award (A): 416,667 @ $0EDGAR
2023-11-144Dais Craig — CHIEF FINANCIAL OFFICERGrant/award (A): 973,633 @ $0EDGAR
2023-07-174Moss Dana J — DirectorGrant/award (A): 250,000 @ $0EDGAR
2023-06-304Scott John K Jr. — Director, 10% ownerGrant/award (A): 12,200,000 @ $0.09EDGAR
2023-06-154Scott John K Jr. — Director, 10% ownerOther (J): 990 · Grant/award (A): 11,508,672 · Purchase (P): 11,969 (derivative) @ $100 · Conversion (C): 11,969 (derivative) @ $100EDGAR
2023-06-124Stefanelli Jill — DirectorGrant/award (A): 250,000 @ $0EDGAR
2022-11-304Bhalla Amit — DirectorGrant/award (A): 1,250 @ $0EDGAR
2022-11-304Witter Malcolm G — DirectorGrant/award (A): 1,250 @ $0EDGAR
2022-11-304/AWitter Malcolm G — DirectorGrant/award (A): 1,250 @ $0EDGAR
2022-11-304Scott John K Jr. — Director, 10% ownerGrant/award (A): 1,250 @ $0EDGAR
2022-11-304Wilson Joshua M. — DirectorGrant/award (A): 30,000 @ $0.00EDGAR
2022-11-304CAPPELLO ALEXANDER L — DirectorGrant/award (A): 1,250 @ $0EDGAR
2022-11-014Bhalla Amit — DirectorGrant/award (A): 2,500 @ $0EDGAR
2022-11-014Witter Malcolm G — DirectorGrant/award (A): 2,500 @ $0EDGAR
2022-11-014Scott John K Jr. — Director, 10% ownerGrant/award (A): 2,500 @ $0EDGAR
2022-11-014CAPPELLO ALEXANDER L — DirectorGrant/award (A): 2,500 @ $0EDGAR
2022-10-044Bhalla Amit — DirectorGrant/award (A): 2,500 @ $0EDGAR
2022-10-044Witter Malcolm G — DirectorGrant/award (A): 2,500 @ $0EDGAR
2022-10-044Scott John K Jr. — Director, 10% ownerGrant/award (A): 2,500 @ $0EDGAR
2022-10-044CAPPELLO ALEXANDER L — DirectorGrant/award (A): 2,500 @ $0EDGAR
2022-09-134Rosol Michael Stanley — Chief Medical OfficerGrant/award (A): 28,150 @ $0 · Grant/award (A): 13,000 @ $0EDGAR
2022-09-014Bhalla Amit — DirectorGrant/award (A): 2,500 @ $0EDGAR
2022-09-014Witter Malcolm G — DirectorGrant/award (A): 2,500 @ $0 · Purchase (P): 115 (derivative) · Purchase (P): 115 (derivative)EDGAR
2022-09-014Scott John K Jr. — Director, 10% ownerGrant/award (A): 2,500 @ $0 · Sale (S): 1,740 (derivative) @ $1,379.31 · Purchase (P): 2,400 (derivative) · Purchase (P): 2,400 (derivative)EDGAR
2022-09-014CAPPELLO ALEXANDER L — DirectorGrant/award (A): 2,500 @ $0EDGAR
2022-08-014Bhalla Amit — DirectorGrant/award (A): 2,500 @ $0EDGAR
2022-08-014Witter Malcolm G — DirectorGrant/award (A): 2,500 @ $0EDGAR
2022-08-014Scott John K Jr. — Director, 10% ownerGrant/award (A): 2,500 @ $0EDGAR
2022-08-014CAPPELLO ALEXANDER L — DirectorGrant/award (A): 2,500 @ $0EDGAR
2022-07-054Bhalla Amit — DirectorGrant/award (A): 2,500 @ $0EDGAR
2022-07-054Witter Malcolm G — DirectorGrant/award (A): 2,500 @ $0EDGAR
2022-07-054Scott John K Jr. — Director, 10% ownerGrant/award (A): 2,500 @ $0EDGAR
2022-07-054CAPPELLO ALEXANDER L — DirectorGrant/award (A): 2,500 @ $0EDGAR
2022-06-014Bhalla Amit — DirectorGrant/award (A): 2,500 @ $0EDGAR
2022-06-014Witter Malcolm G — DirectorGrant/award (A): 2,500 @ $0EDGAR
2022-06-014Scott John K Jr. — Director, 10% ownerGrant/award (A): 2,500 @ $0EDGAR
2022-06-014CAPPELLO ALEXANDER L — DirectorGrant/award (A): 2,500 @ $0EDGAR
2022-05-034Bhalla Amit — DirectorGrant/award (A): 2,500 @ $0EDGAR
2022-05-034Witter Malcolm G — DirectorGrant/award (A): 2,500 @ $0EDGAR
2022-05-034Scott John K Jr. — Director, 10% ownerGrant/award (A): 2,500 @ $0 · Purchase (P): 3,260 · Sale (S): 50,000 (derivative) @ $2.30 · Purchase (P): 1,740 (derivative) @ $0.80EDGAR
2022-05-034CAPPELLO ALEXANDER L — DirectorGrant/award (A): 2,500 @ $0EDGAR
2022-03-314Bhalla Amit — DirectorGrant/award (A): 2,500 @ $0EDGAR
2022-03-314Witter Malcolm G — DirectorGrant/award (A): 2,500 @ $0EDGAR
2022-03-314Scott John K Jr. — Director, 10% ownerGrant/award (A): 2,500 @ $0EDGAR
2022-03-314CAPPELLO ALEXANDER L — DirectorGrant/award (A): 2,500 @ $0EDGAR
2022-03-084/ARosol Michael Stanley — Chief Medical OfficerGrant/award (A): 100,000 (derivative) @ $0.00EDGAR
2022-03-014Scott John K Jr. — Director, 10% ownerGrant/award (A): 2,500 @ $0EDGAR
2022-03-014CAPPELLO ALEXANDER L — DirectorGrant/award (A): 2,500 @ $0EDGAR

Recent 8-K events — NAVIDEA BIOPHARMACEUTICALS, INC.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2023-12-018-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
3.02 — Unregistered Sales of Equity Securities
9.01 — Financial Statements and Exhibits
EDGAR
2023-11-168-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2023-08-088-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2023-07-288-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.07 — Submission of Matters to a Vote of Security Holders
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2023-07-138-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2023-07-068-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2023-06-168-K3.03 — Material Modification to Rights of Security Holders
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2023-06-168-K1.01 — Entry into a Material Definitive Agreement
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2023-06-058-K1.01 — Entry into a Material Definitive Agreement
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.02 — Unregistered Sales of Equity Securities
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2023-05-258-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=NAVB returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs